Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India-Reference-Cited by-同舟云学术

Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India

Published:2020-08 Issue:4 Volume:39 Page:388-397
ISSN:0254-8860
Container-title:Indian Journal of Gastroenterology
language:en
Short-container-title:Indian J Gastroenterol

Author:

Sahu Pabitra,Vuyyuru Sudheer K.,Kante Bhaskar,Agarwal Ashish,Sharma Raju,Das Prasenjit,Panwar Rajesh,Jain Saransh,Bopanna Sawan,Makharia Govind,Kedia Saurabh,Ahuja Vineet^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s12664-020-01043-w.pdf

Reference33 articles.

1. Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14:111–9.

2. Singh P, Ananthakrishnan A, Ahuja V. Pivot to Asia: inflammatory bowel disease burden. Intest Res. 2017;15:138–41.

3. Billiet T, Rutgeerts P, Ferrante M, Van Assche G, Vermeire S. Targeting TNF-α for the treatment of inflammatory bowel disease. Expert Opin Biol Ther. 2014;14:75–101.

4. Van der Valk ME, Mangen MJ, Leenders M, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study. Gut. 2014;63:72–9.

5. D'Haens GR, Panaccione R, Higgins PD, et al. The London Position Statement of the World Congress of Gastroenterology on biological therapy for IBD with the European Crohn’s and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol. 2011;106:199–212.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study;Clinical Pharmacology & Therapeutics;2023-08-16

2. Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remission;Clinical and Experimental Medicine;2023-01-12

3. Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study;Alimentary Pharmacology & Therapeutics;2021-06-20

4. Infliximab discontinuation in patients with ulcerative colitis;The Lancet Gastroenterology & Hepatology;2021-06

5. Indian Journal of Gastroenterology July–August 2020;Indian Journal of Gastroenterology;2020-08